Psychological status features and life quality self-evaluation in patients with malignant lymphoma treated with different chemotherapy approach
Psychological status features and life quality self-evaluation in patients with ag-gressive and indolent malignant lymphoma treated with common methods of treatment such as polychemotherapy and polychemotherapy combined with homogeneous antibodies (rituximab) are being presented. Significant diagnostic criteria that give characteristics of the psychological status and life quality in given group of patients during the remission that happens in a month after the completion of 6 chemotherapy courses are being identified. Emotional disorders such as increased anxiety, fear, tension and feeling of threatening risk have been verified in the groups of indolent and aggressive forms of malignant lymphomas. It was revealed that these disorders do not level after the course of highly toxic polychemotherapy with rituximab but even increase, affecting the patients activity. It was found out that assignment of up-to-date highly toxic chemotherapy to patients with indolent malignant lymphomas result in more severe decrease of life quality compared with the same during the treatment with traditional cytostatic therapy. The application of developed diagnostic criteria will enable to evaluate the efficacy of a chosen anticancer therapy scheme.